Stockscreener 앱 받기
89.17
2.28%
-2.08
시간 외 거래:
88.75
-0.42
-0.47%
Abbott Laboratories 주식(ABT)의 최신 뉴스
This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In - Yahoo Finance
Abbott Offered Faulty Health Plan Option, Ex-Worker Says - Law360
Abbott Diabetes And Cancer Milestones Contrast With Prolonged Share Price Weakness - Yahoo Finance
Abbott (ABT) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Abbott office in Easton part of multi-state portfolio sale - The Business Journals
Abbott Laboratories Hit With Lawsuit Over Healthcare Costs (1) - Bloomberg Law News
Abbott Defeats Account Manager’s Sexualized Workplace Claim - Bloomberg Law News
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story - Yahoo Finance
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
BSX, MDT Top Abbott Laboratories Stock on Price & Potential - Trefis
Abbott Laboratories: A Better Than 5 Years AgoBut Still Not A Buy - Seeking Alpha
3 Large Cap Defensive Dividend Stocks With Underestimated Payout Power - simplywall.st
Abbott (ABT) Secures CE Mark for World’s First Dual Glucose‑Ketone Sensing Technology for Diabetes - Insider Monkey
Abbott Laboratories stock (US0028241000): New filing, modest gain, and valuation focus - AD HOC NEWS
Abbott Laboratories stock (US0028241000): analysts stay positive as new diabetes data and steady gai - AD HOC NEWS
Abbott Laboratories price gives in to negative pressureForecast today09-06-2026 - Economies.com
ABT DCF Analysis: Intrinsic Value $93 vs Price $90 - GuruFocus
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $109 - Moomoo
Richard W. Allen Sells Shares in Abbott Laboratories, Ameriprise Financial and More - Investing.com Nigeria
Similac baby formula maker sued by Allegheny County parents over infant’s 2011 death - TribLIVE.com
Abbott Laboratories, maker of Similac baby formula, sued by Allegheny County parents over infant’s 2011 death - TribLIVE.com
Governor Abbott, Secretary Rollins Update Texans On Screwworm Response At Kerrville Lab - Office of the Texas Governor (.gov)
Abbott's Healthy Food Rx Program Shows Promising Results for Dia - GuruFocus
Is It Time To Revisit Abbott Laboratories (ABT) After This Year’s Share Price Slump? - Yahoo Finance
Can Beyond Meat's Pivot to Protein Drinks Change the Investment Thesis? - The Motley Fool
Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock - Insider Monkey
LIVE: Abbott activates emergency center for screwworm response, USDA says 2 more Texas cases - KLBK
BofA Securities Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $120 - 富途牛牛
Abbott activates emergency center for screwworm response, USDA says 2 more Texas cases - KXAN Austin
Food boxes and coaches tied to better diabetes health, less food insecurity - Stock Titan
Abbott Laboratories (ABT) Up 6.4% Following European CE Mark Approval of Dual Glucose-Ketone Sensors - Meyka
Abbott Buy Rating Reaffirmed as Analyst Sees Accelerating 2027 Earnings; $120 Price Target Maintained on Libre Duo Growth Potential - TipRanks
Abbott Laboratories (ABT) Investor Outlook: Harnessing A 28.79% Potential Upside - DirectorsTalk Interviews
Abbott (ABT) Highlights Dangers of Diabetic Ketoacidosis in New Research Findings - GuruFocus
Abbott Laboratories (ABT) Is Up 6.4% After European Approval of Dual Glucose‑Ketone Sensors - simplywall.st
Abbott studies reinforce DKA opportunity following dual sensor milestone - Drug Delivery Business
Abbott reports rising DKA hospitalizations among diabetics - Investing.com
Kids’ diabetes hospital stays now mostly from ketoacidosis, Abbott finds - Stock Titan
Abbott Laboratories slammed on its post-Exact Sciences guidance - MSN
ABT Stock Quote Price and Forecast - CNN
Abbott Says Timing Mismatch Lets $8B Gain Go Untaxed - Law360
What is Abbott Tokenized Stock (Ondo)(ABTON) Coin? A comprehensive guide you shouldn’t miss - WEEX
A Grandma Bought PediaSure To Help Her Grandson Grow — Now, Abbott Is In Federal Court - Benzinga
Abbott Laboratories stock is getting decimated, but the smart money senses opportunity - MSN
Better medical device stock right now: Abbott Laboratories vs. Dexcom - MSN
Is It Too Late to Buy Abbott Laboratories (ABT) After 4.4% Rally? GF Value Says Undervalued - GuruFocus
Judge Questions Fees In Abbott Investors' $40M Formula Deal - Law360
Abbott Can’t Drop PediaSure Children’s Growth Deception Suit - Bloomberg Law News
Abbott Labs must face lawsuit over PediaSure children's growth claims - Reuters
Abbott Labs must face lawsuit over PediaSure children’s growth claims - The Mighty 790 KFGO
Abbott Laboratories Stock (ABT) Closed Up by 4.18% on Jun 4: Drivers Behind the Movement - TradingKey
Abbott Laboratories stock (US0028241000): shares advance on strong US trading - AD HOC NEWS
[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a Promising CAGR of 25.60% by 2034 - GlobeNewswire Inc.
Abbott Laboratories stock gains as Norges Bank acquires new institutional position - Traders Union
Abbott Laboratories shares jump as stock buying pressure builds - Traders Union
Abbott shares rise as investors refocus on diabetes tech and cancer-diagnostics momentum - Quiver Quantitative
Abbott Laboratories on Pace for Largest Percent Increase Since April 2023 -- Data Talk - Moomoo
Abbott Addresses a Major Diabetes Care Gap With Tech Innovation - Yahoo Finance
Jim Cramer Says “No One Disputes the Science and Commercial Smarts of Abbott” - Insider Monkey
1.65%
자본화:
|
볼륨(24시간):